{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:10:42Z","timestamp":1762528242000,"version":"build-2065373602"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA043815"],"award-info":[{"award-number":["R01 DA043815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01327-4","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:23:28Z","timestamp":1762521808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Allocative efficiency of opioid overdose prevention strategies for people incarcerated in New Jersey"],"prefix":"10.1186","volume":"22","author":[{"given":"Joy D.","family":"Scheidell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jillian M.","family":"Frechette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarlise N.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinlian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prima","family":"Manandhar-Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Kaldany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista L.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam P.","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine I.-Shin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyanna L.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Scott","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"1327_CR1","unstructured":"Centers for Disease Control and Prevention. Opioid Overdose: Understanding the Epidemic 2022 [Available from: https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html."},{"issue":"6","key":"1327_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1327_CR3","unstructured":"Centers for Disease Control and Prevention. Drug Overdose Mortality by State 2022 [Available from: https:\/\/www.cdc.gov\/nchs\/pressroom\/sosmap\/drug_poisoning_mortality\/drug_poisoning.htm."},{"key":"1327_CR4","unstructured":"Ghandnoosh N, Anderson C. Opioids: Treating an Illness, Ending a War: The Sentencing Project; 2017 [Available from: https:\/\/www.sentencingproject.org\/publications\/opioids-treating-illness-ending-war\/."},{"issue":"1","key":"1327_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40352-021-00143-9","volume":"9","author":"CK Scott","year":"2021","unstructured":"Scott CK, Dennis ML, Grella CE, Mischel AF, Carnevale J. The impact of the opioid crisis on U.S. state prison systems. Health Justice. 2021;9(1):17.","journal-title":"Health Justice"},{"key":"1327_CR6","unstructured":"Kuzyk I, Baudoin K, K B. Opioid and criminal justice in CT 2017 [Available from: https:\/\/www.ct.gov\/opm\/lib\/opm\/cjppd\/cjabout\/opioid_presentation_06092017.pdf."},{"key":"1327_CR7","unstructured":"Hennepin County Criminal Justice Coordinating Committee The Opioid Epidemic: Public Safety Interventions & Justice-Invovled Supports 2018 [Available from: https:\/\/www.hennepin.us\/cjcc\/-\/media\/cjcc\/secure-documents\/cjcc-opioid-report-jul-2018.pdf."},{"issue":"9","key":"1327_CR8","doi-asserted-by":"publisher","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","volume":"159","author":"IA Binswanger","year":"2013","unstructured":"Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592\u2013600.","journal-title":"Ann Intern Med"},{"issue":"9","key":"1327_CR9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","volume":"105","author":"EL Merrall","year":"2010","unstructured":"Merrall EL, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction. 2010;105(9):1545\u201354.","journal-title":"Addiction"},{"issue":"1","key":"1327_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/1078345816685311","volume":"23","author":"B Alex","year":"2017","unstructured":"Alex B, Weiss DB, Kaba F, Rosner Z, Lee D, Lim S, et al. Death after jail release. J Correct Health Care. 2017;23(1):83\u20137.","journal-title":"J Correct Health Care"},{"issue":"3","key":"1327_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0558","volume":"1","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman TNA, Chang VW, Binswanger IA. Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Netw Open. 2018;1(3):e180558.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1327_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13722-019-0145-5","volume":"14","author":"PJ Joudrey","year":"2019","unstructured":"Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, et al. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019;14(1):17.","journal-title":"Addict Sci Clin Pract"},{"key":"1327_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.208971","volume":"147","author":"DM Hartung","year":"2023","unstructured":"Hartung DM, McCracken CM, Nguyen T, Kempany K, Waddell EN. Fatal and nonfatal opioid overdose risk following release from prison: a retrospective cohort study using linked administrative data. J Subst Use Addict Treat. 2023;147:208971.","journal-title":"J Subst Use Addict Treat"},{"key":"1327_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109655","volume":"241","author":"AW O'Connor","year":"2022","unstructured":"O\u2019Connor AW, Sears JM, Fulton-Kehoe D. Overdose and substance-related mortality after release from prison in Washington State: 2014\u20132019. Drug Alcohol Depend. 2022;241:109655.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1327_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/add.15640","volume":"117","author":"G Victor","year":"2022","unstructured":"Victor G, Zettner C, Huynh P, Ray B, Sightes E. Jail and overdose: assessing the community impact of incarceration on overdose. Addiction. 2022;117(2):433\u201341.","journal-title":"Addiction"},{"key":"1327_CR16","unstructured":"Stainton LH. State Expands Addiction Treatment for Prisoners 2018 [Available from: https:\/\/www.njspotlightnews.org\/2018\/08\/18-08-08-state-expands-addiction-treatment-for-prisoners\/."},{"key":"1327_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","volume":"99","author":"KE Moore","year":"2019","unstructured":"Moore KE, Roberts W, Reid HH, Smith KMZ, Oberleitner LMS, McKee SA. Effectiveness of medication assisted treatment for opioid use in prison and jail settings: a meta-analysis and systematic review. J Subst Abuse Treat. 2019;99:32\u201343.","journal-title":"J Subst Abuse Treat"},{"key":"1327_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109254","volume":"231","author":"EA Evans","year":"2022","unstructured":"Evans EA, Wilson D, Friedmann PD. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug Alcohol Depend. 2022;231:109254.","journal-title":"Drug Alcohol Depend"},{"key":"1327_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2017.11.023","volume":"184","author":"L Brinkley-Rubinstein","year":"2018","unstructured":"Brinkley-Rubinstein L, McKenzie M, Macmadu A, Larney S, Zaller N, Dauria E, et al. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: findings at 12 months post-release. Drug Alcohol Depend. 2018;184:57\u201363.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1327_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","volume":"75","author":"TC Green","year":"2018","unstructured":"Green TC, Clarke J, Brinkley-Rubinstein L, Marshall BDL, Alexander-Scott N, Boss R, et al. Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system. JAMA Psychiat. 2018;75(4):405\u20137.","journal-title":"JAMA Psychiat"},{"key":"1327_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108937","volume":"227","author":"A Haas","year":"2021","unstructured":"Haas A, Viera A, Doernberg M, Barbour R, Tong G, Grau LE, et al. Post-incarceration outcomes for individuals who continued methadone treatment while in Connecticut jails, 2014\u20132018. Drug Alcohol Depend. 2021;227:108937.","journal-title":"Drug Alcohol Depend"},{"key":"1327_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102841","volume":"91","author":"A Macmadu","year":"2021","unstructured":"Macmadu A, Adams JW, Bessey SE, Brinkley-Rubinstein L, Martin RA, Clarke JG, et al. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: a microsimulation modeling study. Int J Drug Policy. 2021;91:102841.","journal-title":"Int J Drug Policy"},{"key":"1327_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107858","volume":"208","author":"A Macmadu","year":"2020","unstructured":"Macmadu A, Goedel WC, Adams JW, Brinkley-Rubinstein L, Green TC, Clarke JG, et al. Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails. Drug Alcohol Depend. 2020;208:107858.","journal-title":"Drug Alcohol Depend"},{"key":"1327_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108042","volume":"115","author":"BP Horn","year":"2020","unstructured":"Horn BP, Li X, McCrady B, Guerin P, French MT. Cost-effectiveness analysis of a large jail-based methadone maintenance treatment continuation program in New Mexico. J Subst Abuse Treat. 2020;115:108042.","journal-title":"J Subst Abuse Treat"},{"key":"1327_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108292","volume":"217","author":"GA Zarkin","year":"2020","unstructured":"Zarkin GA, Orme S, Dunlap LJ, Kelly SM, Mitchell SG, O\u2019Grady KE, et al. Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail. Drug Alcohol Depend. 2020;217:108292.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1327_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.7036","volume":"6","author":"A Chatterjee","year":"2023","unstructured":"Chatterjee A, Weitz M, Savinkina A, Macmadu A, Madushani RWMA, Potee RA, et al. Estimated costs and outcomes associated with use and nonuse of medications for opioid use disorder during incarceration and at release in Massachusetts. JAMA Netw Open. 2023;6(4):e237036-e.","journal-title":"JAMA Netw Open"},{"key":"1327_CR27","unstructured":"Bronson J., Stroop J., Zimmer S., M. B. Drug use, dependence, and abuse among state prisoners and jail inmates, 2007\u20132009. 2020 [Available from: https:\/\/bjs.ojp.gov\/content\/pub\/pdf\/dudaspji0709.pdf."},{"key":"1327_CR28","unstructured":"Bureau of Justice Statistics UDoJ. Reentry trends in the United States: Inmates returning to the community after serving time in prison 2003 [Available from: https:\/\/bjs.ojp.gov\/content\/pub\/pdf\/reentry.pdf."},{"key":"1327_CR29","unstructured":"State of New Jersey Department of Health. Governor Murphy Signs Legislative Package to Expand Harm Reduction Efforts, Further Commitment to End New Jersey\u2019s Opioid Epidemic 2022 [Available from: https:\/\/www.nj.gov\/health\/news\/2022\/approved\/20220118a.shtml."},{"key":"1327_CR30","unstructured":"Department of Human Services. Murphy Administration Launches Naloxone Distribution Program New Jersey2022 [Available from: https:\/\/www.nj.gov\/humanservices\/news\/pressreleases\/2022\/approved\/20220728.html."},{"issue":"3","key":"1327_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","volume":"37","author":"TW Kinlock","year":"2009","unstructured":"Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O\u2019Grady KE. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat. 2009;37(3):277\u201385.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"1327_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/08897077.2011.620475","volume":"33","author":"JD Lee","year":"2012","unstructured":"Lee JD, Grossman E, Truncali A, Rotrosen J, Rosenblum A, Magura S, et al. Buprenorphine-naloxone maintenance following release from jail. Subst Abus. 2012;33(1):40\u20137.","journal-title":"Subst Abus"},{"issue":"2","key":"1327_CR33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/ADM.0000000000000381","volume":"12","author":"KE Moore","year":"2018","unstructured":"Moore KE, Oberleitner L, Smith KMZ, Maurer K, McKee SA. Feasibility and effectiveness of continuing methadone maintenance treatment during incarceration compared with forced withdrawal. J Addict Med. 2018;12(2):156\u201362.","journal-title":"J Addict Med"},{"key":"1327_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13722-014-0023-0","volume":"10","author":"AD Fox","year":"2015","unstructured":"Fox AD, Maradiaga J, Weiss L, Sanchez J, Starrels JL, Cunningham CO. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder. Addict Sci Clin Pract. 2015;10:2.","journal-title":"Addict Sci Clin Pract"},{"issue":"8","key":"1327_CR35","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","volume":"105","author":"CM Jones","year":"2015","unstructured":"Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55-63.","journal-title":"Am J Public Health"},{"key":"1327_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108315","volume":"128","author":"BA Howell","year":"2021","unstructured":"Howell BA, Puglisi L, Clark K, Albizu-Garcia C, Ashkin E, Booth T, et al. The transitions clinic network: post incarceration addiction treatment, healthcare, and social support (TCN-PATHS): a hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail. J Subst Abuse Treat. 2021;128:108315.","journal-title":"J Subst Abuse Treat"},{"key":"1327_CR37","unstructured":"Beletsky L, LaSalle L, Newman M, Pare J, Tam J, A T. Fatal re-entry: legal and programmatic opportunities to curb opioid overdose among individuals newly released from incarceratio. Northeastern University Law Journal. 2015;7(149)."},{"issue":"1","key":"1327_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13722-022-00313-6","volume":"17","author":"N Krawczyk","year":"2022","unstructured":"Krawczyk N, Bandara S, Merritt S, Shah H, Duncan A, McEntee B, et al. Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative. Addict Sci Clin Pract. 2022;17(1):30.","journal-title":"Addict Sci Clin Pract"},{"key":"1327_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addbeh.2018.03.014","volume":"86","author":"C McClellan","year":"2018","unstructured":"McClellan C, Lambdin BH, Ali MM, Mutter R, Davis CS, Wheeler E, et al. Opioid-overdose laws association with opioid use and overdose mortality. Addict Behav. 2018;86:90\u20135.","journal-title":"Addict Behav"},{"issue":"9","key":"1327_CR40","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ajem.2015.05.022","volume":"33","author":"J Rando","year":"2015","unstructured":"Rando J, Broering D, Olson JE, Marco C, Evans SB. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. Am J Emerg Med. 2015;33(9):1201\u20134.","journal-title":"Am J Emerg Med"},{"key":"1327_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.","journal-title":"BMJ"},{"issue":"6","key":"1327_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/jamainternmed.2019.0272","volume":"179","author":"R Abouk","year":"2019","unstructured":"Abouk R, Pacula RL, Powell D. Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose. JAMA Intern Med. 2019;179(6):805\u201311.","journal-title":"JAMA Intern Med"},{"key":"1327_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugpo.2018.02.008","volume":"55","author":"C Keane","year":"2018","unstructured":"Keane C, Egan JE, Hawk M. Effects of naloxone distribution to likely bystanders: results of an agent-based model. Int J Drug Policy. 2018;55:61\u20139.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1327_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","volume":"158","author":"PO Coffin","year":"2013","unstructured":"Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1327_CR45","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/S2468-2667(17)30006-3","volume":"2","author":"J Uyei","year":"2017","unstructured":"Uyei J, Fiellin DA, Buchelli M, Rodriguez-Santana R, Braithwaite RS. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study. Lancet Public Health. 2017;2(3):e133\u201340.","journal-title":"Lancet Public Health"},{"issue":"4","key":"1327_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jval.2017.07.014","volume":"21","author":"S Langham","year":"2018","unstructured":"Langham S, Wright A, Kenworthy J, Grieve R, Dunlop WCN. Cost-effectiveness of take-home naloxone for the prevention of overdose fatalities among heroin users in the United Kingdom. Value Health. 2018;21(4):407\u201315.","journal-title":"Value Health"},{"key":"1327_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209584","volume":"169","author":"R Martin","year":"2025","unstructured":"Martin R, DaCunha A, Bailey A, Joseph R, Kane K. Evaluating public health vending machine rollout and utilization in criminal-legal settings. J Subst Use Addict Treat. 2025;169:209584.","journal-title":"J Subst Use Addict Treat"},{"key":"1327_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209521","volume":"167","author":"G Victor","year":"2024","unstructured":"Victor G, Hedden-Clayton B, Lenz D, Attaway PR, Ray B. Naloxone vending machines in county jail. J Subst Use Addict Treat. 2024;167:209521.","journal-title":"J Subst Use Addict Treat"},{"key":"1327_CR49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.drugalcdep.2015.06.023","volume":"154","author":"JA Barocas","year":"2015","unstructured":"Barocas JA, Baker L, Hull SJ, Stokes S, Westergaard RP. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Drug Alcohol Depend. 2015;154:283\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"1327_CR50","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hec.1483","volume":"19","author":"L Segal","year":"2010","unstructured":"Segal L, Dalziel K, Mortimer D. Fixing the game: are between-silo differences in funding arrangements handicapping some interventions and giving others a head-start? Health Econ. 2010;19(4):449\u201365.","journal-title":"Health Econ"},{"key":"1327_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103786","volume":"110","author":"N Krawczyk","year":"2022","unstructured":"Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerd\u00e1 M. Has the treatment gap for opioid use disorder narrowed in the U.S.? A yearly assessment from 2010 to 2019\u201d. Int J Drug Policy. 2022;110:103786.","journal-title":"Int J Drug Policy"},{"key":"1327_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2022.100052","author":"KM Keyes","year":"2022","unstructured":"Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, et al. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep. 2022. https:\/\/doi.org\/10.1016\/j.dadr.2022.100052.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"1327_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40352-019-0100-2","volume":"7","author":"WJ Ferguson","year":"2019","unstructured":"Ferguson WJ, Johnston J, Clarke JG, Koutoujian PJ, Maurer K, Gallagher C, et al. Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails. Health Justice. 2019;7(1):19.","journal-title":"Health Justice"},{"issue":"3","key":"1327_CR54","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s10461-013-0572-3","volume":"18","author":"R Heimer","year":"2014","unstructured":"Heimer R, Barbour R, Palacios WR, Nichols LG, Grau LE. Associations between injection risk and community disadvantage among suburban injection drug users in southwestern Connecticut, USA. AIDS Behav. 2014;18(3):452\u201363.","journal-title":"AIDS Behav"},{"key":"1327_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.drugalcdep.2018.07.017","volume":"191","author":"PR Freeman","year":"2018","unstructured":"Freeman PR, Hankosky ER, Lofwall MR, Talbert JC. The changing landscape of naloxone availability in the United States, 2011\u20132017. Drug Alcohol Depend. 2018;191:361\u20134.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1327_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality. Ann Intern Med. 2018;169(3):137\u201345.","journal-title":"Ann Intern Med"},{"key":"1327_CR57","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugalcdep.2019.03.004","volume":"199","author":"G Rhee","year":"2019","unstructured":"Rhee G, Rosenheck RA. Association of current and past opioid use disorders with health-related quality of life and employment among US adults. Drug Alcohol Depend. 2019;199:122\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"1327_CR58","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1477-7525-7-78","volume":"7","author":"CA Chong","year":"2009","unstructured":"Chong CA, Li S, Nguyen GC, Sutton A, Levy MH, Butler T, et al. Health-state utilities in a prisoner population: a cross-sectional survey. Health Qual Life Outcomes. 2009;7:78.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"1327_CR59","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/08897077.2021.1986877","volume":"43","author":"CN Behrends","year":"2022","unstructured":"Behrends CN, Gutkind S, Winkelstein E, Wright M, Dolatshahi J, Welch A, et al. Costs of opioid overdose education and naloxone distribution in New York City. Subst Abus. 2022;43(1):692\u20138.","journal-title":"Subst Abus"},{"issue":"13","key":"1327_CR60","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.2009.414","volume":"301","author":"ME Larimer","year":"2009","unstructured":"Larimer ME, Malone DK, Garner MD, Atkins DC, Burlingham B, Lonczak HS, et al. Health care and public service use and costs before and after provision of housing for chronically homeless persons with severe alcohol problems. JAMA. 2009;301(13):1349\u201357.","journal-title":"JAMA"},{"key":"1327_CR61","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.2147\/JPR.S184724","volume":"11","author":"PJ Mallow","year":"2018","unstructured":"Mallow PJ, Belk KW, Topmiller M, Strassels SA. Geographic variation in hospital costs, payments, and length of stay for opioid-related hospital visits in the USA. J Pain Res. 2018;11:3079\u201388.","journal-title":"J Pain Res"},{"issue":"1","key":"1327_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12954-024-01026-6","volume":"21","author":"JD Scheidell","year":"2024","unstructured":"Scheidell JD, Townsend TN, Zhou Q, Manandhar-Sasaki P, Rodriguez-Santana R, Jenkins M, et al. Reducing overdose deaths among persons with opioid use disorder in Connecticut. Harm Reduct J. 2024;21(1):103.","journal-title":"Harm Reduct J"},{"issue":"1","key":"1327_CR63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciac543","volume":"76","author":"H Bradley","year":"2023","unstructured":"Bradley H, Hall EW, Asher A, Furukawa NW, Jones CM, Shealey J, et al. Estimated number of people who inject drugs in the United States. Clin Infect Dis. 2023;76(1):96\u2013102.","journal-title":"Clin Infect Dis"},{"key":"1327_CR64","doi-asserted-by":"publisher","DOI":"10.4137\/SART.S37030","volume":"10","author":"L Naji","year":"2016","unstructured":"Naji L, Dennis BB, Bawor M, Plater C, Pare G, Worster A, et al. A prospective study to investigate predictors of relapse among patients with opioid use disorder treated with methadone. Subst Abuse Res Treat. 2016;10:SART.S37030.","journal-title":"Subst Abuse Res Treat"},{"key":"1327_CR65","unstructured":"Ahmad F, Cisewski J, Rossen L, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics; 2025."},{"issue":"2","key":"1327_CR66","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1360-0443.2003.00264.x","volume":"98","author":"SM Bird","year":"2003","unstructured":"Bird SM, Hutchinson SJ. Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996\u201399. Addiction. 2003;98(2):185\u201390.","journal-title":"Addiction"},{"issue":"7129","key":"1327_CR67","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/bmj.316.7129.426","volume":"316","author":"SR Seaman","year":"1998","unstructured":"Seaman SR, Brettle RP, Gore SM. Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ. 1998;316(7129):426\u20138.","journal-title":"BMJ"},{"issue":"8","key":"1327_CR68","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/add.13803","volume":"112","author":"A Bukten","year":"2017","unstructured":"Bukten A, Stavseth MR, Skurtveit S, Tverdal A, Strang J, Clausen T. High risk of overdose death following release from prison: variations in mortality during a 15-year observation period. Addiction. 2017;112(8):1432\u20139.","journal-title":"Addiction"},{"issue":"4","key":"1327_CR69","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/MLR.0b013e31815c31a7","volume":"46","author":"RS Braithwaite","year":"2008","unstructured":"Braithwaite RS, Meltzer DO, King JT Jr., Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care. 2008;46(4):349\u201356.","journal-title":"Med Care"},{"issue":"3","key":"1327_CR70","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00304-2","volume":"7","author":"MA Irvine","year":"2022","unstructured":"Irvine MA, Oller D, Boggis J, Bishop B, Coombs D, Wheeler E, et al. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. Lancet Public Health. 2022;7(3):e210\u20138.","journal-title":"Lancet Public Health"},{"key":"1327_CR71","unstructured":"Substance Abuse and Mental Health Services Administration. Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings. Rockville, MD; 2019. Contract No.: HHS Publication No. PEP19-MATUSECJS."},{"issue":"12","key":"1327_CR72","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1111\/add.15565","volume":"116","author":"S Bandara","year":"2021","unstructured":"Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B. Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters. Addiction. 2021;116(12):3473\u201381.","journal-title":"Addiction"},{"key":"1327_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108262","volume":"128","author":"SM Murphy","year":"2021","unstructured":"Murphy SM, Laiteerapong N, Pho MT, Ryan D, Montoya I, Shireman TI, et al. Health economic analyses of the justice community opioid innovation network (JCOIN). J Subst Abuse Treat. 2021;128:108262.","journal-title":"J Subst Abuse Treat"},{"key":"1327_CR74","unstructured":"National Institutes on Health. The HEALing Communities Study 2023 [Available from: https:\/\/heal.nih.gov\/research\/research-to-practice\/healing-communities."},{"issue":"2","key":"1327_CR75","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37259","volume":"4","author":"BP Linas","year":"2021","unstructured":"Linas BP, Savinkina A, Madushani R, Wang J, Eftekhari Yazdi G, Chatterjee A, et al. Projected estimates of opioid mortality after community-level interventions. JAMA Netw Open. 2021;4(2):e2037259.","journal-title":"JAMA Netw Open"},{"issue":"25","key":"1327_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm8147","volume":"8","author":"EJ Stringfellow","year":"2022","unstructured":"Stringfellow EJ, Lim TY, Humphreys K, DiGennaro C, Stafford C, Beaulieu E, et al. Reducing opioid use disorder and overdose deaths in the United States: a dynamic modeling analysis. Sci Adv. 2022;8(25):eabm8147.","journal-title":"Sci Adv"},{"issue":"9","key":"1327_CR77","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.2105\/AJPH.2015.302681","volume":"105","author":"L Beletsky","year":"2015","unstructured":"Beletsky L, Cochrane J, Sawyer AL, Serio-Chapman C, Smelyanskaya M, Han J, et al. Police encounters among needle exchange clients in Baltimore: drug law enforcement as a structural determinant of health. Am J Public Health. 2015;105(9):1872\u20139.","journal-title":"Am J Public Health"},{"issue":"1","key":"1327_CR78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.drugpo.2013.06.005","volume":"25","author":"L Beletsky","year":"2014","unstructured":"Beletsky L, Heller D, Jenness SM, Neaigus A, Gelpi-Acosta C, Hagan H. Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. Int J Drug Policy. 2014;25(1):105\u201311.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1327_CR79","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12954-022-00604-w","volume":"19","author":"AS Bennett","year":"2022","unstructured":"Bennett AS, Scheidell J, Bowles JM, Khan M, Roth A, Hoff L, et al. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City. Harm Reduct J. 2022;19(1):20.","journal-title":"Harm Reduct J"},{"issue":"9","key":"1327_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053334","volume":"11","author":"JD Scheidell","year":"2021","unstructured":"Scheidell JD, Dyer TV, Hucks-Ortiz C, Abrams J, Mazumdar M, Cleland C, et al. Characterisation of social support following incarceration among Black sexual minority men and transgender women in the HPTN 061 cohort study. BMJ Open. 2021;11(9):e053334.","journal-title":"BMJ Open"},{"key":"1327_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191912064","author":"JD Scheidell","year":"2022","unstructured":"Scheidell JD, Kapadia F, Turpin RE, Mazumdar M, Dyer TV, Feelemyer J, et al. Incarceration, social support networks, and health among Black sexual minority men and transgender women: evidence from the HPTN 061 study. Int J Environ Res Public Health. 2022. https:\/\/doi.org\/10.3390\/ijerph191912064.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"1327_CR82","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1176\/appi.ps.20220310","volume":"74","author":"M Enich","year":"2023","unstructured":"Enich M, Treitler P, Swarbrick M, Belsky L, Hillis M, Crystal S. Peer health navigation experiences before and after prison release among people with opioid use disorder. Psychiatr Serv. 2023;74(7):737\u201345.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"1327_CR83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40352-021-00138-6","volume":"9","author":"E Kaplowitz","year":"2021","unstructured":"Kaplowitz E, Truong AQ, Macmadu A, Peterson M, Brinkley-Rubinstein L, Potter N, et al. Fentanyl-related overdose during incarceration: a comprehensive review. Health Justice. 2021;9(1):13.","journal-title":"Health Justice"},{"key":"1327_CR84","unstructured":"Dydyk AM JN, Gupta M. . Opioid Use Disorder. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan."},{"key":"1327_CR85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsat.2015.05.001","volume":"57","author":"RE Clark","year":"2015","unstructured":"Clark RE, Baxter JD, Aweh G, O\u2019Connell E, Fisher WH, Barton BA. Risk factors for relapse and higher costs among Medicaid members with opioid dependence or abuse: opioid agonists, comorbidities, and treatment history. J Subst Abuse Treat. 2015;57:75\u201380.","journal-title":"J Subst Abuse Treat"},{"key":"1327_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108146","volume":"119","author":"K Cioe","year":"2020","unstructured":"Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients\u2019 and providers\u2019 perspectives of medications for treatment of opioid use disorder. J Subst Abuse Treat. 2020;119:108146.","journal-title":"J Subst Abuse Treat"},{"key":"1327_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108690","volume":"137","author":"E Kaplowitz","year":"2022","unstructured":"Kaplowitz E, Truong AQ, Berk J, Martin RA, Clarke JG, Wieck M, et al. Treatment preference for opioid use disorder among people who are incarcerated. J Subst Abuse Treat. 2022;137:108690.","journal-title":"J Subst Abuse Treat"},{"key":"1327_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100419","author":"RA Martin","year":"2023","unstructured":"Martin RA, Alexander-Scott N, Berk J, Carpenter RW, Kang A, Hoadley A, et al. Post-incarceration outcomes of a comprehensive statewide correctional MOUD program: a retrospective cohort study. The Lancet Regional Health \u2013 Americas. 2023. https:\/\/doi.org\/10.1016\/j.lana.2022.100419.","journal-title":"The Lancet Regional Health \u2013 Americas"},{"key":"1327_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108529","volume":"222","author":"W Vail","year":"2021","unstructured":"Vail W, Faro E, Watnick D, Giftos J, Fox AD. Does incarceration influence patients\u2019 goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail. Drug Alcohol Depend. 2021;222:108529.","journal-title":"Drug Alcohol Depend"},{"key":"1327_CR90","volume":"8","author":"CMT Nguyen","year":"2024","unstructured":"Nguyen CMT, Kubiak G, Dixit N, Young SA, Hayes JR. Evaluating barriers to Opioid Use Disorder treatment from patients\u2019 perspectives. PRiMER. 2024;8:11.","journal-title":"PRiMER"},{"issue":"4","key":"1327_CR91","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.5340","volume":"8","author":"E Flanagan Balawajder","year":"2025","unstructured":"Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, et al. Barriers to universal availability of medications for opioid use disorder in US jails. JAMA Netw Open. 2025;8(4):e255340-e.","journal-title":"JAMA Netw Open"},{"key":"1327_CR92","doi-asserted-by":"publisher","first-page":"1141093","DOI":"10.3389\/fpubh.2023.1141093","volume":"11","author":"W Bremer","year":"2023","unstructured":"Bremer W, Plaisance K, Walker D, Bonn M, Love JS, Perrone J, et al. Barriers to opioid use disorder treatment: a comparison of self-reported information from social media with barriers found in literature. Front Public Health. 2023;11:1141093.","journal-title":"Front Public Health"},{"key":"1327_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2024.116660","volume":"346","author":"TJ Stopka","year":"2024","unstructured":"Stopka TJ, Estadt AT, Leichtling G, Schleicher JC, Mixson LS, Bresett J, et al. Barriers to opioid use disorder treatment among people who use drugs in the rural United States: a qualitative, multi-site study. Soc Sci Med. 2024;346:116660.","journal-title":"Soc Sci Med"},{"key":"1327_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209441","author":"D Bowser","year":"2024","unstructured":"Bowser D, Bohler R, Davis MT, Hodgkin D, Horgan C. Payment-related barriers to medications for opioid use disorder: a critical review of the literature and real-world application. J Subst Use Addict Treat. 2024. https:\/\/doi.org\/10.1016\/j.josat.2024.209441.","journal-title":"J Subst Use Addict Treat"},{"issue":"3","key":"1327_CR95","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.sapharm.2023.12.001","volume":"20","author":"S Nedjat","year":"2024","unstructured":"Nedjat S, Wang Y, Eshtiaghi K, Fleming M. Is there a disparity in medications for opioid use disorder based on race\/ethnicity and gender? A systematic review and meta-analysis. Res Social Adm Pharm. 2024;20(3):236\u201345.","journal-title":"Res Social Adm Pharm"},{"key":"1327_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00736-7","author":"MR Khan","year":"2023","unstructured":"Khan MR, Hoff L, Elliott L, Scheidell JD, Pamplin JR, Townsend TN, et al. Racial\/ethnic disparities in opioid overdose prevention: comparison of the naloxone care cascade in White, Latinx, and Black people who use opioids in New York City. Harm Reduct J. 2023. https:\/\/doi.org\/10.1186\/s12954-023-00736-7.","journal-title":"Harm Reduct J"},{"issue":"10","key":"1327_CR97","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2105\/AJPH.2021.306431","volume":"111","author":"MR Larochelle","year":"2021","unstructured":"Larochelle MR, Slavova S, Root ED, Feaster DJ, Ward PJ, Selk SC, et al. Disparities in opioid overdose death trends by race\/ethnicity, 2018\u20132019, from the HEALing communities study. Am J Public Health. 2021;111(10):1851\u20134.","journal-title":"Am J Public Health"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01327-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:05:48Z","timestamp":1762527948000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01327-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01327-4","relation":{},"ISSN":["1477-7517"],"issn-type":[{"type":"electronic","value":"1477-7517"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}